Lung cancer is one of the most common forms of cancer worldwide and it is often associated with myths and misinformation. As such, it is important to be aware of the myths and misconceptions surrounding lung cancer in order to ensure that you are receiving the most accurate information.
The myth about smoking associated with lung cancer
One common myth about lung cancer is that it can be caused by smoking. While smoking is known to be a risk factor, it is essential to understand that it is not a cause of lung cancer. Other risk factors associated with lung cancer, such as age, genetics, and exposure to carcinogens, can increase someone’s likelihood of developing the disease.
Environmental side myth
Another myth is that environmental factors, such as pollution, can be a cause of lung cancer. While ecological pollutants and hazardous chemicals can lead to many types of illnesses and diseases, it is important to remember that not all pollutants are directly linked to lung cancer. Instead of blaming pollution, people should focus on changing their lifestyles and limiting their exposure to harmful chemicals.
Family history of lung cancer
Another myth is that if you have a family history of lung cancer, you will also develop the disease. While it is true that some people are more likely to inherit genetic variations that increase their vulnerability to developing the disease, having an immediate family member with cancer does not guarantee that you will develop the same illness. Ultimately, there is no single, definitive cause of lung cancer, so it is important to stay informed and receive regular check-ups to ensure your health.
lung cancer can be prevented
It is also important to understand the myth that not all lung cancers are preventable. This statement is actually false; many cases of lung cancer can be prevented by making lifestyle changes like quitting smoking, reducing air pollution exposure, and avoiding carcinogenic chemicals. Additionally, being aware of the other risk factors associated with lung cancer and getting regular check-ups is a great way to ensure your health and reduce your risk of developing the disease.
Treatment with chemo drugs
Osimertinib (Tagrisso) is a targeted, oral and reversible inhibitor of the epidermal growth factor receptor tyrosine kinase family. It is used to treat certain types of non-small cell lung cancer (NSCLC). Osimertinib has been shown to be more tolerable and effective than other targeted therapy agents in the treatment of NSCLC.
Targetted action of this drug in the body
Tab Osimertinib 80mg uses for targeting the epidermal growth factor receptor (EGFR) tyrosine kinase family, which is over-expressed in NSCLC cells. It works by blocking the activity of this receptor, thus blocking the growth and spread of cancer cells. This prevents cancer from developing and growing. Osimertinib offers a number of benefits to people with NSCLC compared to chemotherapy or other targeted therapy agents.
Positive effects of osimertinib drug
Osimertinib can be used as a first-line treatment for people with EGFR mutation-positive NSCLC, where it can be used to replace chemotherapy. It can also be used to replace other targeted agents, such as gefitinib or erlotinib, when they have become ineffective or if the patient cannot tolerate them. In comparison to other agents, osimertinib has been found to have a longer progression-free survival time and a higher overall response rate. This makes it an attractive option for those who require targeted therapy.
Side effects of this drug will progressively slow down with time
The most common side effect experienced by patients being treated with osimertinib is diarrhea, which can be managed with additional supportive care. Other less common side effects that can be experienced include rash, fatigue, cough, shortness of breath, and headache.
Summary understanding of the overall effects of this drug
In summary, tab tagrisso 80mg is a targeted and oral therapeutic agent used to treat certain types of NSCLC. It works by inhibiting the epidermal growth factor receptor tyrosine kinase family, which is over-expressed in NSCLC cells. It offers a number of benefits compared to chemotherapy and other targeted agents, such as longer progression-free survival time and a higher overall response rate. The most common side effect experienced is diarrhea. Osimertinib is an effective and tolerable treatment option for people with EGFR mutation-positive NSCLC.
it is important to be aware of the myths and misconceptions surrounding lung cancer in order to ensure that you are receiving the most accurate information. Though there is no one cause of the disease, there are steps that can be taken to reduce your risk of developing it, such as quitting smoking, avoiding pollutants, and getting regular check-ups. So remember to stay informed and practice healthy lifestyle habits to reduce your risk of developing this deadly form of cancer.